CWP
GSK icon

Clark Wealth Partners’s GSK GSK Stock Holding History

Clark Wealth Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.1K Buy
456
+4
+0.9% +$212 0.01% 171
2026
Q1 		$25.2K Buy
452
+3
+0.7% +$163 0.02% 156
2025
Q4 		$22K Hold
449
– – 0.01% 164
2025
Q3 		$22K Buy
449
+10
+2% +$391 0.01% 164
2025
Q2 		$16.9K Buy
439
+5
+1% +$191 0.01% 167
2025
Q1 		$16.8K Buy
434
+5
+1% +$183 0.01% 162
2024
Q4 		$14.5K Buy
+429
New +$15.4K 0.01% 148

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Clark Wealth Partners's GSK Position: Q2 2026 in Review

Clark Wealth Partners increased its GSK (GSK) stake by 0.88% in Q2 2026, buying an estimated $212 and bringing the position to 456 shares worth $24.1K. The position accounts for 0.01% of the portfolio, ranked #171.

Clark Wealth Partners first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $25.2K in Q1 2026. 999 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Clark Wealth Partners held 456 shares of GSK worth $24.1K as of Q2 2026.
  • Clark Wealth Partners bought 4 GSK shares in Q2 2026, an estimated $212.
  • GSK made up 0.01% of Clark Wealth Partners's portfolio in Q2 2026, its #171 holding.
  • Clark Wealth Partners first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • Clark Wealth Partners's GSK position peaked at $25.2K in Q1 2026.
  • 999 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Clark Wealth Partners's 13F filing for Q2 2026, filed 28 Jul 2026.